Virulence of Pseudomonas aeruginosa in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle

被引:2
|
作者
Papa, Rosanna [1 ]
Imperlini, Esther [2 ]
Trecca, Marika [1 ]
Paris, Irene [1 ]
Vrenna, Gianluca [3 ,4 ]
Artini, Marco [1 ]
Selan, Laura [1 ]
机构
[1] Sapienza Univ, Dept Publ Hlth & Infect Dis, p Aldo Moro 5, I-00185 Rome, Italy
[2] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-0100 Viterbo, Italy
[3] Childrens Hosp, Res Unit Diagnost & Management Innovat, I-00165 Rome, Italy
[4] Inst Res Bambino Gesu, I-00165 Rome, Italy
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 01期
关键词
oxygen concentration; antimicrobial resistance; biofilm; pyocyanin; pyoverdine; motility; proteases; PYOCYANIN PRODUCTION; ADAPTATION;
D O I
10.3390/antibiotics13010001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The airways of cystic fibrosis (CF) patients are colonized by many pathogens and the most common is Pseudomonas aeruginosa, an environmental pathogen that is able to infect immunocompromised patients thanks to its ability to develop resistance to conventional antibiotics. Over 12% of all patients colonized by P. aeruginosa harbour multi-drug resistant species. During airway infection in CF, P. aeruginosa adopts various mechanisms to survive in a hostile ecological niche characterized by low oxygen concentration, nutrient limitation and high osmotic pressure. To this end, P. aeruginosa uses a variety of virulence factors including pigment production, biofilm formation, motility and the secretion of toxins and proteases. This study represents the first report that systematically analyzes the differences in virulence features, in normoxia and anoxia, of clinical P. aeruginosa isolated from CF patients, characterized by multi- or pan-drug antibiotic resistance compared to antibiotic sensitive strains. The virulence features, such as biofilm formation, protease secretion and motility, are highly diversified in anaerobiosis, which reflects the condition of chronic CF infection. These findings may contribute to the understanding of the real-world lifestyle of pathogens isolated during disease progression in each particular patient and to assist in the design of therapeutic protocols for personalized medicine.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
    Nina Cramer
    Jens Klockgether
    Colin F Davenport
    Burkhard Tümmler
    Molecular and Cellular Pediatrics, 1 (Suppl 1)
  • [32] Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis
    Farrell, PM
    Shen, GH
    Splaingard, M
    Colby, CE
    Laxova, A
    Kosorok, MR
    Rock, MJ
    Mischler, EH
    PEDIATRICS, 1997, 100 (05) : E2
  • [33] Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Taccetti, G
    Campana, S
    Marianelli, L
    JOURNAL OF PEDIATRICS, 1996, 129 (04): : 619 - 620
  • [34] Pseudomonas aeruginosa in cystic fibrosis: A chronic cheater
    Waters, Christopher M.
    Goldberg, Joanna B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (14) : 6525 - 6527
  • [35] MICROEVOLUTION OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS LUNGS
    Cramer, N.
    Klockgether, J.
    Davenport, C. F.
    Tuemmler, B.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 324 - 324
  • [36] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
    Döring, G
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) : 653 - 653
  • [37] Pseudomonas aeruginosa and the Biofilm in People with Cystic Fibrosis
    Cohen-Cymberknoh, Malena
    PEDIATRIC PULMONOLOGY, 2023, 58 : S63 - S63
  • [38] CYSTIC-FIBROSIS AND PSEUDOMONAS-AERUGINOSA
    PIER, GB
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (03) : 222 - 222
  • [39] MICROEVOLUTION OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS LUNGS
    Klockgether, J.
    Cramer, N.
    Fischer, S.
    Dorda, M.
    Wiehlmann, L.
    Tummler, B.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S337 - S337
  • [40] Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis
    Woo, Taylor E.
    Duong, Jessica
    Jervis, Nicole M.
    Rabin, Harvey R.
    Parkins, Michael D.
    Storey, Douglas G.
    MICROBIOLOGY-SGM, 2016, 162 (12): : 2126 - 2135